High cytokine expression and reduced ovarian reserve in patients with Hodgkin lymphoma or non-Hodgkin lymphoma

Paradisi Roberto; Vicenti Rossella; Macciocca Maria; Seracchioli Renato; Rossi Stefania; Fabbri Raffaella

首页> 外文期刊>Fertility and Sterility: Official Journal of the American Fertility Society, Pacific Coast Fertility Society, and the Canadian Fertility and Andrology Society >High cytokine expression and reduced ovarian reserve in patients with Hodgkin lymphoma or non-Hodgkin lymphoma

【24h】

High cytokine expression and reduced ovarian reserve in patients with Hodgkin lymphoma or non-Hodgkin lymphoma

机译：霍奇金淋巴瘤或非霍奇金淋巴瘤患者的细胞因子高表达和卵巢储备减少

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective: To investigate the ovarian reserve in female lymphoma patients and the potential relationships with the cytokine network.

机译：目的：探讨女性淋巴瘤患者的卵巢储备及其与细胞因子网络的潜在关系。

著录项

来源
《Fertility and Sterility: Official Journal of the American Fertility Society, Pacific Coast Fertility Society, and the Canadian Fertility and Andrology Society》 |2016年第5期|共7页
作者
Paradisi Roberto; Vicenti Rossella; Macciocca Maria; Seracchioli Renato; Rossi Stefania; Fabbri Raffaella;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类妇科学;
关键词
Antimullerian hormone; cytokines; Hodgkin lymphoma; non-Hodgkin lymphoma; fertility preservation;

机译：抗苗勒激素;细胞因子;霍奇金淋巴瘤;非霍奇金淋巴瘤;生育力保存;

相似文献

外文文献
中文文献
专利

1. High cytokine expression and reduced ovarian reserve in patients with Hodgkin lymphoma or non-Hodgkin lymphoma [J] . Paradisi Roberto, Vicenti Rossella, Macciocca Maria, Fertility and Sterility: Official Journal of the American Fertility Society, Pacific Coast Fertility Society, and the Canadian Fertility and Andrology Society . 2016,第5期

机译：霍奇金淋巴瘤或非霍奇金淋巴瘤患者的细胞因子高表达和卵巢储备减少
2. Lack of prognostic significance of BCL2 and p53 protein overexpression in elderly patients with diffuse large B-cell non-Hodgkin's lymphoma: results from a population-based non-Hodgkin's lymphoma registry. [J] . Maartense E, Kramer MH, le Cessie S, Leukemia and lymphoma . 2004,第1期

机译：老年弥漫性大B细胞非霍奇金淋巴瘤患者中BCL2和p53蛋白过表达的预后意义缺乏：基于人群的非霍奇金淋巴瘤登记的结果。
3. Clinical significance of suppressor of cytokines signalling-3 mRNA expression from patients with non-Hodgkin lymphoma under chemotherapy [J] . Fadia M. Attiaa∗ Amany M. Hassana Nermine N. El-Maraghyb and Gehan H. Ibrahiumc Cancer Biomarkers . 2012,第1期

机译：非霍奇金淋巴瘤化疗患者细胞因子signal-3 mRNA表达抑制子的临床意义
4. Robust Diagnosis of Non-Hodgkin Lymphoma Phenotypes Validated on Gene Expression Data fromDifferent Laboratories [C] . Gyan Bhanot, Gabriela Alex International Workshop on Bioinformatics and Systems Biology . 2005

机译：从Drifferent Laboratories的基因表达数据验证的非霍奇金淋巴瘤表型的鲁棒诊断
5. Estimation of G-CSF effectiveness in reducing neutropenia hospitalization among Non-Hodgkin's Lymphoma (NHL) patients treated with anthracycline-based chemotherapy. [D] . Pan, Xiaoyun. 2010

机译：估计G-CSF在以蒽环类为基础的化学疗法治疗的非霍奇金淋巴瘤（NHL）患者中减少中性粒细胞减少症住院的有效性。
6. Prognostic nomogram incorporating inflammatory cytokines for overall survival in patients with aggressive non-Hodgkins lymphoma [O] . Huijuan Zhong, Jia Chen, Shu Cheng, 2019

机译：侵袭性非霍奇金淋巴瘤患者的总生存率与炎性细胞因子的预后列线图
7. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large cell B-Cell Non-Hodgkin’s lymphoma1,2 1Expert panel members and authors of the review are: Theresa Hahn, PhD, Roswell Park Cancer Institute, Buffalo, NY; Steven N. Wolff, MD, Vanderbilt University, Nashville, TN, Myron Czuczman, MD, Roswell Park Cancer Institute, Buffalo, NY; Richard I. Fisher, MD, Cardinal Bernardin Cancer Center, Loyola University, Chicago, IL; Hillard M. Lazarus, MD, Comprehensive Cancer Center, University Hospitals of Cleveland, Case Western Reserve University, Cleveland, OH; Philip L. McCarthy, MD, Roswell Park Cancer Institute, Buffalo, NY; Julie Vose, MD, University of Nebraska Medical Center, Omaha, NE; Lisa Warren, Cure for Lymphoma Foundation, New York, NY; and Richard Watt, MD, United Resource Networks, Minneapolis, MN. 2Reference: Hahn T, Wolff SN, Czuczman M, et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of diffuse large cell B-cell non-Hodgkin’s lymphoma: an evidence-based review. Biol Blood Marrow Transplant. 2001;7:308–331. [O] . 2003

机译：造血干细胞移植的细胞毒性治疗在治疗弥漫性大细胞B细胞非霍奇金淋巴瘤1,2中的作用1，专家小组成员和评价的作者是：纽约州布法罗罗斯威尔公园癌症研究所的特蕾莎·哈恩博士；田纳西州纳什维尔范德比尔特大学医学博士斯蒂芬·沃尔夫（Steven N. Wolff），纽约州布法罗罗斯维尔公园癌症研究所医学博士迈伦·库兹曼（Myron Czuczman）；理查德·费舍尔（Richard I. Fisher）医学博士，伊利诺伊州芝加哥洛约拉大学贝纳尔丁枢机主教癌症中心；俄亥俄州克利夫兰凯斯西储大学克利夫兰大学医院综合癌症中心医学博士Hillard M. Lazarus；纽约州布法罗罗斯韦尔公园癌症研究所医学博士Philip L.内布拉斯加州奥马哈市内布拉斯加大学医学中心医学博士Julie Vose；丽莎·沃伦（Lisa Warren），纽约州纽约市淋巴瘤基金会的治疗；和明尼苏达州明尼阿波利斯市联合资源网络公司的医学博士Richard Watt。 2参考文献：Hahn T，Wolff SN，Czuczman M等。一项基于证据的综述：造血干细胞移植的细胞毒性治疗在弥漫性大细胞B细胞非霍奇金淋巴瘤治疗中的作用。 Biol骨髓移植。 2001; 7：308-331。

High cytokine expression and reduced ovarian reserve in patients with Hodgkin lymphoma or non-Hodgkin lymphoma

摘要

著录项

相似文献

相关主题

期刊订阅